Cystic fibrosis has inflammation as one of its primary pathological drivers. Current treatments are poor at controlling and halting the progression of inflammatory events, frequently made worse by concurrent infection. Using anakinra, a non-glycosylated recombinant version of IL-1Ra, offers a…
The pathophysiology of cardiovascular disease and protein-energy wasting, which are significant risk factors for morbidity and mortality in individuals with end-stage kidney disease, are linked to inflammation. Anti-cytokine therapy has been proposed to reduce inflammation and improve outcomes. Anakinra’s effectiveness,…
Kineret Injection reduces the symptoms and prevents moderate to severe rheumatoid arthritis in people from getting worse. If you have tried one or more disease-modifying antirheumatic medications, but they did not work well enough, your doctor may prescribe Kineret. Your doctor…
The immediate reason for death in patients today with severe respiratory distress brought on by COVID-19 is cytokine syndromes. Given that cytokine storms can be fatal, it’s crucial to treat patients with the proper medications, Anakinra, based on their particular…
Do you know what Kineret is? Popular prescription medicine is called Kineret. For individuals with moderate to severe rheumatoid arthritis, it is to reduce symptoms and slow the deterioration of the condition. If disease modifying antirheumatic medications (DMARDs) has not…